Mary C Schroeder1, Yu-Yu Tien2, Lillian M Erdahl3, Ingrid M Lizarraga3, Brahmendra R Viyyuri4, Sonia L Sugg3. 1. Division of Health Services Research, University of Iowa College of Pharmacy, Iowa City, IA. Electronic address: mary-schroeder@uiowa.edu. 2. Data Center, Spokane Regional Health District, Spokane, WA. 3. Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA. 4. Division of Health Services Research, University of Iowa College of Pharmacy, Iowa City, IA.
Abstract
BACKGROUND: Increasingly, women are undergoing contralateral prophylactic mastectomy for the treatment of unilateral breast cancer. The relationship between contralateral prophylactic mastectomy and breast reconstruction, postsurgical complications, additional breast-related procedures, and cost has not received the attention it deserves. METHODS: Data from the New York comprehensive, all-age, all-payer, Statewide Planning and Research Cooperative System were queried to identify patients undergoing unilateral mastectomy or contralateral prophylactic mastectomy from 2008 to 2010. We identified the complications and breast-related procedures within a 2-y follow-up period. Costs of the index operation and subsequent follow-up were estimated. Univariate and multivariate analyses were conducted. RESULTS: Of 12,959 women identified, 10.7% underwent contralateral prophylactic mastectomy. On univariate analysis, contralateral prophylactic mastectomy was positively associated with breast reconstruction, complications, and additional breast-related procedures. Rates of complications were greater for women who had contralateral prophylactic mastectomy (29.5% vs 20.8% for unilateral mastectomy group; P < .001), but not after stratifying by breast reconstruction. Additional breast-related procedures were more common in the contralateral prophylactic mastectomy group than in the unilateral mastectomy group, but only for those who underwent breast reconstruction (82.8% vs 72.1%; P < .001). Unadjusted costs were greater for women with contralateral prophylactic mastectomy than with unilateral mastectomy but did not differ between the groups after adjusting for breast reconstruction and additional breast-related procedures. CONCLUSION: Women who elected contralateral prophylactic mastectomy in this population-based study were more likely to have both breast reconstruction and additional breast-related procedures than women with unilateral mastectomy. The greater rates of complications and costs associated with contralateral prophylactic mastectomy were explained by breast reconstruction and additional breast-related procedures. Surgeons should counsel patients regarding the increased cost and likelihood of undergoing additional, non-complication-related procedures after contralateral prophylactic mastectomy with breast reconstruction.
BACKGROUND: Increasingly, women are undergoing contralateral prophylactic mastectomy for the treatment of unilateral breast cancer. The relationship between contralateral prophylactic mastectomy and breast reconstruction, postsurgical complications, additional breast-related procedures, and cost has not received the attention it deserves. METHODS: Data from the New York comprehensive, all-age, all-payer, Statewide Planning and Research Cooperative System were queried to identify patients undergoing unilateral mastectomy or contralateral prophylactic mastectomy from 2008 to 2010. We identified the complications and breast-related procedures within a 2-y follow-up period. Costs of the index operation and subsequent follow-up were estimated. Univariate and multivariate analyses were conducted. RESULTS: Of 12,959 women identified, 10.7% underwent contralateral prophylactic mastectomy. On univariate analysis, contralateral prophylactic mastectomy was positively associated with breast reconstruction, complications, and additional breast-related procedures. Rates of complications were greater for women who had contralateral prophylactic mastectomy (29.5% vs 20.8% for unilateral mastectomy group; P < .001), but not after stratifying by breast reconstruction. Additional breast-related procedures were more common in the contralateral prophylactic mastectomy group than in the unilateral mastectomy group, but only for those who underwent breast reconstruction (82.8% vs 72.1%; P < .001). Unadjusted costs were greater for women with contralateral prophylactic mastectomy than with unilateral mastectomy but did not differ between the groups after adjusting for breast reconstruction and additional breast-related procedures. CONCLUSION: Women who elected contralateral prophylactic mastectomy in this population-based study were more likely to have both breast reconstruction and additional breast-related procedures than women with unilateral mastectomy. The greater rates of complications and costs associated with contralateral prophylactic mastectomy were explained by breast reconstruction and additional breast-related procedures. Surgeons should counsel patients regarding the increased cost and likelihood of undergoing additional, non-complication-related procedures after contralateral prophylactic mastectomy with breast reconstruction.
Authors: Robert C Keskey; A Scott LaJoie; Brad S Sutton; In K Kim; William G Cheadle; Kelly M McMasters; Nicolas Ajkay Journal: Ann Surg Oncol Date: 2017-12 Impact factor: 5.344
Authors: Ashish A Deshmukh; Scott B Cantor; Melissa A Crosby; Wenli Dong; Yu Shen; Isabelle Bedrosian; Susan K Peterson; Patricia A Parker; Abenaa M Brewster Journal: Ann Surg Oncol Date: 2014-05-09 Impact factor: 5.344
Authors: Megan E Miller; Tomasz Czechura; Brigid Martz; Mary E Hall; Catherine Pesce; Nora Jaskowiak; David J Winchester; Katharine Yao Journal: Ann Surg Oncol Date: 2013-07-19 Impact factor: 5.344
Authors: Andrea M Covelli; Nancy N Baxter; Margaret I Fitch; David R McCready; Frances C Wright Journal: Ann Surg Oncol Date: 2014-09-05 Impact factor: 5.344
Authors: Judy C Boughey; Stephanie R Schilz; Holly K Van Houten; Lin Zhu; Elizabeth B Habermann; Valerie Lemaine Journal: Ann Surg Oncol Date: 2017-08-01 Impact factor: 5.344
Authors: Judy C Boughey; Deanna J Attai; Steven L Chen; Hiram S Cody; Jill R Dietz; Sheldon M Feldman; Caprice C Greenberg; Rena B Kass; Jeffrey Landercasper; Valerie Lemaine; Fiona MacNeill; Julie A Margenthaler; David H Song; Alicia C Staley; Lee G Wilke; Shawna C Willey; Katharine A Yao Journal: Ann Surg Oncol Date: 2016-07-28 Impact factor: 5.344